Let V denote the classical Volterra operator. In this work, sharp estimates of the norm of (I − V)n acting on Lp [0, 1], for 1 ⩽ p ⩽ ∞, are obtained. As a consequence, I − V acting on Lp [0, 1], with 1 ⩽ p ⩽ ∞, is power bounded if and only if p = 2. Thus the Volterra operator characterizes when Lp [0, 1] is a Hilbert space. By means of sharp estimates of the L1‐norm of the nth partial sums of the generating function of the Laguerre polynomials on the unit circle, it is also proved that I − V is uniformly Kreiss bounded on the spaces Lp [0,1], for 1 ⩽ p ⩽ ∞.
A bounded linear operator T on a Banach space is said to be Kreiss bounded if there is a constant C > 0 such that falsefalse∥false(T−λfalse)−1∥⩽Cfalse(|λ|−1false)−1 for ∣ λ ∣ > 1. If the same upper estimate holds for each of the partial sums of the resolvent, then T is said to be uniformly Kreiss bounded. This is, for instance, true for power bounded operators. For finite‐dimensional Banach spaces, Kreiss' Matrix Theorem asserts that Kreiss boundedness is equivalent to T being power bounded. Thus, in the infinite‐dimensional setting, even a much stronger property than Kreiss boundedness still does not imply power boundedness. It is also shown that, for general operators, uniform Abel boundedness characterizes Cesàro boundedness and, as a consequence, uniform Kreiss boundedness is characterized in terms of a Cesàro type boundedness of order 1. 2000 Mathematics Subject Classification 47B38, 47G10.
We propose a method of constructing examples in operator ergodic theory which unifies and extends some previously known examples. It also allows us to answer several questions that have been open for some time (including a question of Allan [1]).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.